DeepMed Research

Turku University Hospital

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: Subsidiary

Established: 1756-01-01

Employees: -

Market Cap: -

Website: http://www.vsshp.fi

Clinical Trials

MRI Guided Transurethral HIFU for Various Prostate Diseases

Not Applicable

Completed

Conditions: Localised Prostate Cancer
Locally Advanced Prostate Cancer
Locally Recurrent Prostate Cancer
Benign Prostatic Hyperplasia

Interventions: Device: MRI guided transurethral HIFU ablation of prostatic tissue

First Posted Date: 2017-11-22

Last Posted Date: 2024-11-25

Lead Sponsor: Turku University Hospital

Target Recruit Count: 87

Registration Number: NCT03350529

Locations: 🇫🇮
Department of Urology, Turku, Finland

Assessing Neurovisual Function in Patients With Cognitive Impairment

Not Applicable

Conditions: Glaucoma and Mild Cognitive Impairment
Healthy
Glaucoma
Mild Cognitive Impairment

Interventions: Device: Ocusweep test battery
Diagnostic Test: Neuropsychological test battery

First Posted Date: 2017-11-06

Last Posted Date: 2018-02-19

Lead Sponsor: Turku University Hospital

Target Recruit Count: 60

Registration Number: NCT03333096

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Adenosine and A2A Receptors in Human Brown Adipose Tissue

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: Cold exposure
Drug: Adenosine

First Posted Date: 2017-10-31

Last Posted Date: 2017-11-06

Lead Sponsor: Turku University Hospital

Target Recruit Count: 11

Registration Number: NCT03327168

The Effect of ADT on PSMA-PET.

Not Applicable

Conditions: Prostate Cancer

Interventions: Drug: GnRH antagonist

First Posted Date: 2017-10-18

Last Posted Date: 2017-10-18

Lead Sponsor: Turku University Hospital

Target Recruit Count: 30

Registration Number: NCT03313726

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Variation of Genes Controlling Carbohydrate and Lipid Metabolism

Recruiting

Conditions: Lipid Metabolism Disorders
Cardiovascular Diseases
Obesity
PreDiabetes
Diabetes Mellitus, Type 2
Insulin Resistance

First Posted Date: 2017-10-16

Last Posted Date: 2021-10-13

Lead Sponsor: Turku University Hospital

Target Recruit Count: 2050

Registration Number: NCT03310502

Locations: 🇫🇮
Turku PET Centre (Turku University Hospital), Turku, Finland

Secretin Activates Human Brown Fat and Induces Satiation.

Phase 2

Completed

Conditions: Obesity

Interventions: Drug: Secretin Human
Drug: Saline Solution
Other: Cold exposure

First Posted Date: 2017-09-25

Last Posted Date: 2019-12-23

Lead Sponsor: Turku University Hospital

Target Recruit Count: 23

Registration Number: NCT03290846

Locations: 🇫🇮
Turku PET Centre, Turku, Finland

Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects

Not Applicable

Conditions: Acute Appendicitis

Interventions: Drug: Ertapenem followed by levofloxacin and metronidazole
Other: Placebo
Procedure: Appendectomy
Drug: Moxifloxacin

First Posted Date: 2017-08-22

Last Posted Date: 2020-11-10

Lead Sponsor: Turku University Hospital

Target Recruit Count: 200

Registration Number: NCT03257423

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Magnetic Ureteral Stent Symptoms - a Comparison to Standard Ureteral Stent as Perceived By the Patient (MAGUSS)

Not Applicable

Conditions: Kidney Stone
Urinary Tract Stone

Interventions: Procedure: ureteral double-J stent removal using magnet
Procedure: ureteral double-J stent removal using cystoscopy

First Posted Date: 2017-08-22

Last Posted Date: 2021-10-08

Lead Sponsor: Turku University Hospital

Target Recruit Count: 170

Registration Number: NCT03257306

Locations: 🇫🇮
Keski-Suomi Central Hospital, Jyväskylä, Finland
🇫🇮
Turku University Hospital, Turku, Finland
🇫🇮
Satakunta Central Hospital, Pori, Finland

Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis

Not Applicable

Active, not recruiting

Conditions: Acute Appendicitis

Interventions: Drug: Ertapenem
Drug: Moxifloxacin

First Posted Date: 2017-08-02

Last Posted Date: 2020-11-12

Lead Sponsor: Turku University Hospital

Target Recruit Count: 552

Registration Number: NCT03236961

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis

Not Applicable

Conditions: Acute Appendicitis

Interventions: Other: Placebo
Drug: Ertapenem

First Posted Date: 2017-07-31

Last Posted Date: 2020-11-10

Lead Sponsor: Turku University Hospital

Target Recruit Count: 147

Registration Number: NCT03234296

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy